Article Details

Why Investors Should Love Pfizer's Acquisition of Trillium | The Motley Fool

Retrieved on: 2021-09-04 09:55:48

Tags for this article:

Click the tags to see associated articles and topics

Why Investors Should Love Pfizer's Acquisition of Trillium | The Motley Fool. View article details on HISWAI: https://www.fool.com/investing/2021/09/04/why-investors-should-love-pfizers-acquisition-of-t/

Excerpt

Pfizer plans to acquire Trillium Therapeutics for nearly $2.3 billion. · Trillium's pipeline fits really well with Pfizer's oncology programs. · The price tag of ...

Article found on: www.fool.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up